Poor pregnancy outcome for women with Type 2 diabetes [2]

Diabetic Medicine

Volumn 20, Issue 6, 2003, Pages 506-507

  Hadden, D R ^a   Cull, C A ^b   Croft, D J ^b   Holman, R R ^b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

CONGENITAL MALFORMATION; FEMALE; FETUS DEATH; HUMAN; LETTER; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; SPONTANEOUS ABORTION; UNITED KINGDOM;

ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; GREAT BRITAIN; HUMANS; INFANT; INFANT MORTALITY; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME;

EID: 0038798527     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2003.00955_2.x     Document Type: Letter

References (4)

1. The Diabetes Control and Complications Research Group (DCCT Group). Pregnancy outcomes in the Diabetes Control and Complications Trial. Am J Obstetrics Gynecol 1996; 174: 1343-1353.
2. UKPDS Group. UK Prospective Diabetes Study VIII: study design, progress and performance. Diabetologia 1991; 34: 877-890.
3. UKPDS Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
4. Macfarlane A, Mugford M, Henderson J, Furtado A, Stevens J, Dunn A. Birth Count, Statistics of Pregnancy and Childbirth. London: The Stationery Office Books, 2000.